Thanks Sydney, however my question relates to revenues.
On 15th June the company said:
With the launch in May 2010 of the Wireless PulmoTrack? and WHolter products, the full KSX product suite has now been completed and shipping of orders has commenced. As such, from a position of very small initial sales approx. six months ago, demand for the KarmelSonix? products has shown a steady increase such that the sales for the last 3 months (April-June, 2010) are expected to be US$300,000. It is also expected that this rate of sales will continue to increase over the coming quarters as the awareness of KSX products continues to spread and their acceptance as being valuable devices for the monitoring and management of asthma also continues to grow
Revenue has gone down, not increased which isn't a good sign and I haven't found any explanation from the company.
Does anyone on here have any explanation? These products have been in the market place for 12 months now, but don't appear to be selling....
KSX Price at posting:
1.1¢ Sentiment: LT Buy Disclosure: Held